Accounting for the High Enrollment of African Americans on Winship Cancer Institute's Myeloma Clinical Trials.

ABSTRACT:

Background

Thirty-four percent of Multiple Myeloma (MM) clinical trial participants at Winship Cancer Institute (Winship) are African American (AA); however, AAs make up only 4.5 percent of myeloma clinical trial participants in the United States. Given our high enrollment, we aimed to measure AAs' trust in providers and identify if clinical trial enrollment barriers exist.

Methodology

A member of the ethics research team surveyed AA patients who had consented to a MM clinical trial at Winship. Three validated surveys were used: Trust in Medical Research (TMR); Human Connection (THC) which measures how much patients feel they are heard and valued by their physicians; and the Duke Intrinsic Religiosity Scale (DUREL) which measures strength of religious engagement and belief.

SUBMITTER: McClary TS 

PROVIDER: S-EPMC10062432 | biostudies-literature | 2023 Apr

REPOSITORIES: biostudies-literature